Karen Lynn Chandler Johnson, MD, MPH WORK - Office of ...

Recommendations

Info

TONE Ancillary Insulin Study. Principal Investigator: Karen C. Johnson, MD, MPH. Experienced gained in hypertension and the relationship of glucose tolerance and hyperinsulinemia. Funded by the General Clinical Research Center (GCRC) at the University of Tennessee, Memphis. 1993 - 1996. A Randomized, Double blind, Placebo-controlled, Clinical Trial to Study the Effects of the 21 mg Nicotine Patch as Compared to Placebo Patch on Blood Glucose and Insulin Levels in Premenopausal Women Smokers. Principal Investigator: Karen C. Johnson, MD, MPH. Experience gained in smoking cessation and body weight. Funded by the General Clinical Research Center (GCRC) at the University of Tennessee, Memphis. 1992 - 1998. General Clinical Research Center (GCRC) Funded Research Projects Role on Project: Co-Investigator A Clinical Trial of OTC Therapy for Vasomotor Symptoms-Pilot. Principal Investigator: Margret DeBon, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. This study examined the effect of the nicotine patch on vasomotor symptoms in postmenopausal women. Funded by the General Clinical Research Center (GCRC) at the University of Tennessee, Memphis. 2004 – 2007. Assessment of Androgenic Hormones in Patients with Coronary Heart Disease: Relationship to Insulin Resistance, Truncal Obesity, and Hyperlipidemia. Principal Investigator: Marshall B. Elam, MD, PhD. Co-Investigator: Karen C. Johnson, MD, MPH. This study examined the association of lower DHEA levels, insulin resistance, and truncal obesity in persons with cardiovascular disease compared to age matched controls. Funded by the General Clinical Research Center (GCRC) at the University of Tennessee, Memphis. 1997 - 1999. Bone Turnover Markers in CHARM Participants. Principal Investigator: Suzanne Satterfield, MD, DrPH. Co-Principal Investigator: Karen C. Johnson, MD, MPH. Experience gained in assessing the effects of hormonal contraceptives on bone turnover markers in premenopausal women. Funded by the General Clinical Research Center (GCRC) at the University of Tennessee, Memphis. 1994 - 1998. Other Research Projects Role on Project: Principal Investigator BRIDGES Study. A multicenter clinical trial to evaluate a new measure for urinary incontinence. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Pfizer Inc. with a subcontract with UCSF. $101,611. 2008 – 2010. ExCel Study. An international multicenter clinical trial to determine if an aromatase inhibitor can prevent breast cancer in postmenopausal women at high risk for breast cancer. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by National Cancer Institute of Canada. $800,000. 2004 – 2011. CHIMES. A multicenter clinical trial to investigate if a mixture of Chinese herbs can relieve vasomotor symptoms in postmenopausal women. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Bionova. $243,084. 2005-2007. 12
Medal. A Clinical trial to examine the effects of an investigational drug on osteoarthritis and rheumatoid arthritis. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Novartis. $20,184. 2003 - 2006. Coral Study. Clinical trial to examine the effects of an investigational drug on osteopenia. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Pfizer Inc. $107,303. 2003 - 2005. Pharmaceutical Study using an investigational drug for smoking cessation. Principal Investigator: Karen C. Johnson, M.D., M.P.H. Funded by Sanofi Syntholabo. $250,000. 2002-2004. Horizon Study. A Clinical trial to examine the effects of an investigational drug on osteoporosis. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Novartis. $143,588. 2002 - 2007. Pearl Study. A Clinical trial to examine the effects of an investigational drug on osteoporosis. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Pfizer Inc. $739,516. 2001 - 2008. Pharmaceutical Study on Bone Mineral Density and Contraception. . Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Pharmacia Upjohn. $117,500. 2001- 2004. Angelique Study. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Berlex. $38,288. 2001 - 2003. Ultra Study. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Berlex. $150,000. 2000-2003. Preference Study. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Merck & Co., Inc. $30,000. 2000-2001. Soy Intervention Program (SIP). Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Protein Technologies. $180,000. 1999 - 2000. Access of Over-the-Counter Nicotine Replacement Therapy Products by Minors. Principal Investigator: Karen C. Johnson, MD, MPH. Experienced gained in access to nicotine replacement products (patch and gum) by minors in the Memphis area. Grant funded by the Partnership For Women's and Children's Health. $24,000. 1997 - 1998. Exercise Counseling by Resident Physician Project. Principal Investigator at the University of Tennessee, Memphis Site: Karen C. Johnson, MD, MPH. Coordinating Center Principal Investigator: Laura Rogers, MD. Augusta GA. Experienced gained in a multi-center study assessing exercise counseling given by resident physicians in their continuity care clinic. No extramural funding. 1997. Pharmaceutical Study on Prevention of Osteoporosis. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by SmithKline Beecham Pharmaceuticals. $431,400. 1997 - 1999. Pharmaceutical Study on Vasomotor Symptoms. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by Advanced Care Products. $32,000. 1997 - 1998. Pharmaceutical Study on Bone Mineral Density and Contraception. Principal Investigator: Karen C. Johnson, MD, MPH. Funded by the UpJohn Company. $360,000. 1994 - 2002. The Effect of a Physician Smoking Cessation Educational Program on Patient Smoking Cessation Rates Measured by Salivary Cotinine Levels: A Randomized Clinical Trial. Principal 13
Page 1 and 2: CURRICULUM VITAE NAME: Karen Lynn C
Page 3 and 4: Vice Chairman, University of Tennes
Page 5 and 6: Smoking Cessation and Disease Preve
Page 7 and 8: Major Causes of Mortality in the U.
Page 9 and 10: Systolic Blood Pressure Interventio
Page 11: Dynamics of Health, Aging, and Body
Page 15 and 16: Pharmaceutical Study with Antihyper
Page 17 and 18: Chlebowski RT, Johnson KC, Lane D,
Page 19 and 20: Smoking and Pancreatic Cancer: A Po
Page 21 and 22: Bonds D, Larson JC, Schwartz AV, St
Page 23 and 24: Manson JE, Lewis CE, Kotchen JM, Al
Page 25 and 26: Kroenke CH, Stefanick ML, Wallace R
Page 27 and 28: Oophorectomy is Associated with Hig
Page 29 and 30: Li R, Johnson KC, O’Sullivan MJ,
Page 31 and 32: Harshfield GA, Somes GW, Richey PA,
Page 33 and 34: President of the Faculty Senate at
Page 35: American College of Preventive Medi

Karen Lynn Chandler Johnson, MD, MPH WORK - Office of ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?